Unveiling 6 Analyst Insights On Treace Medical Concepts
Portfolio Pulse from Benzinga Insights
Analysts have shown a negative shift in sentiment towards Treace Medical Concepts (NASDAQ:TMCI) over the last quarter, with a significant decrease in the average 12-month price target by 48.39%. The company's financials show strong revenue growth but challenges in profitability and asset utilization.
May 16, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have shown a negative shift in sentiment towards Treace Medical Concepts (NASDAQ:TMCI) over the last quarter, with a significant decrease in the average 12-month price target by 48.39%. The company's financials show strong revenue growth but challenges in profitability and asset utilization.
The significant decrease in the average price target by 48.39% indicates a negative shift in analyst sentiment. Despite strong revenue growth, the company's challenges in profitability and asset utilization contribute to the bearish outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100